Gururaj Shivange

Affiliations reported with papers

Linked publications

A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle 2022

A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors 2021

Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies 2021

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody 2020

Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer 2020

A Single-Agent Dual-Specificity Targeting of FOLR1 and DR5 as an Effective Strategy for Ovarian Cancer 2018

Related research

FOLR1-anchored DR5 bispecific antibody

DR5 agonism and PD-L1 immune evasion

Surface charge and DR5 antibody response

TRIM37 in breast-cancer outcomes

Furin disruption in SARS-CoV-2 models